Navigation Links
APO in Medical News

The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time

November Is National Alzheimer's Disease Awareness Month--The Apo E Gene Diet--A Solution for Preventing and Reversing Heart Disease, Alzheimer's Disease, and Other Chronic Illnesses. THE APO E GENE DIET WINS ITS SECOND BOOK AWARD in "Health: Diet and Weight Loss" category of National...

Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention

A diet book geared to genetic blueprints from Elite Books TUCSON, Ariz., Nov. 5 /PRNewswire/ -- We all carry the Apo E gene. It plays a key role in the development of Alzheimer's Disease and heart disease, along with a host of chronic ailments. And it is greatly affected by diet. In he...

Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug

...vernment simplify the process of getting urgently needed drugs to Africa. apo Triavir is a combination of 300 mg Zidovudine, 150 mg Lamivudine and 200 mg... be sold in Canada until the relevant patents expire. Apotex is producing apo Triavir at cost, with the price quoted in the Tender at 19.5 cents (US) per...

New Gene-Based Therapy an Alternative to Vytorin and Statins in Heart Disease Prevention and Treatment

... apo E Gene Diet offers cholesterol lowering solution ...ronic symptoms of heart disease by focusing on the apo E gene and advanced cholesterol tests. "We have ...anges have been made that support their particular apo E gene." Scientists have known since the early 9...

Abbott's Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study

...estricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate, to reduce elevated total cholesterol, LDL-C, apo B, and triglyceride levels, and to increase HDL-C in patients with primary hypercholesterolemia and mixed dyslipidemia. In patients with a history of ...

New research suggests hearts are experts at self-preservation

...ery disease and heart attack by feeding the genetically modified mice (apoE-/-) a high-fat diet typical of people's diets in North America and the UK. apo E-/- mice fed a normal rodent diet for the same period do not develop coronary disease. The genetic modification in apoE-/- involves changing choleste...

Study Downgrades Gene as Heart Risk Factor

... Screening for variations in apo gene not warranted, researchers say TU...h analysis of previously published studies. The apo gene comes in three varieties -- E2, E3 and E4. Al... coronary outcome showed that the association with apo E variants showed that the links were not as stron...

Use of certain lipid measures not more effective in predicting coronary heart disease

... The lipid measure apolipoprotein (apo) B: apo A-I ratio is not a better predictor of coronary he...ent years, some evidence has suggested that higher apo B (the primary protein component of LDL) and lower apo A-I (the primary protein component of high-density...

Gene Transfer Using Mutant Form of Good Cholesterol Cuts Vascular Plaque and Inflammation

...has been uncertainty and controversy about whether apo A-I Milano is a better form of HDL than the “wild type” (regular) apo A-I in terms of protective effect against atherosc...r inflammation than the normal (wild type) form of apo A-I,” said Shah, the article’s senior author. ...

Gene Activity connected to Schizophrenia

...nts with schizophrenia had nearly three times the gene expression of apolipoprotein L1, a protein that is manufactured by a family of genes called the apo L family. These genes play an important role in cholesterol transport. Cholesterol is important in the adult brain as well as during its early develop...

More>>

APO in Biological Technology

SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models

CALGARY, May 19 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, today reported encouraging data from the Company's Apo AI(Milano) development program. Results from recent preclinical studies show that SemBi...

SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)

Company Achieves Important Milestone in Development of Next Generation Cardiovascular Drug CALGARY, June 5 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company dedicated to developing a portfolio of therapeutic proteins for metabolic and...

SemBioSys updates Apo AI development program

TSX symbol: SBS - Canadian Biotechnology Company confirms commercial expression levels of Apo AI Milano variant and clarifies status of native Apo AI - CALGARY, Aug. 22 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developi...

Data for SemBioSys' insulin to be presented at the American Diabetes Association's 69th Scientific Sessions

...rograms include insulin (SBS-1000, regulated as a biosimilar in Europe) and apo AIMilano, a next-generation cardiovascular therapy. SemBioSys is listed on ...ion and timely and successful completion of clinical studies, the fact that apo AIMilano is currently a development stage drug, the establishment of corpor...

SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC

...for a $1.5 million loan for the development of its apo AIMilano candidate. AVAC is a private, not-for-pro... installments based on the execution of short term apo AIMilano development milestones expected to be com...ds the achievement of near-term objectives for our apo AIMilano candidate and allow us to leverage additi...

SemBioSys provides update on insulin program

...and industrial products. The Company's current pharmaceutical development programs include insulin (SBS-1000, regulated as a biosimilar in Europe) and apo AIMilano, a next-generation cardiovascular therapy. SemBioSys is listed on the Toronto Stock Exchange under the ticker SBS. More information is availa...

SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin

...rograms include insulin (SBS-1000, regulated as a biosimilar in Europe) and apo AI(Milano), a next-generation cardiovascular therapy. SemBioSys is listed o...ion and timely and successful completion of clinical studies, the fact that apo AI(Milano) is currently a development stage drug, the establishment of corp...

SemBioSys announces senior management changes

... the negotiations now underway for our insulin and apo AI candidates." James Szarko joined SemBioSys in...non-profit sectors. "We believe with insulin and apo AI that we have only begun to exploit the propriet...ent and clinical milestones within our insulin and apo AI programs. This will enable us to partner these ...

SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin

... the rapidly expanding global diabetes market, and apo AI(Milano). apo AI(Milano) is a variant of apo AI, the major protein associated with high density...

SemBioSys begins phase I/II trial of insulin produced in plant seeds

... large pharmaceutical partners for our insulin and apo AI Milano programs." SemBioSys prepared the cl... the rapidly expanding global diabetes market, and apo AI Milano. apo AI Milano is a variant of...

More>>

APO in Biological Definition

Apoptosis

... In biology , apoptosis (from the Greek words apo = from and ptosis = falling, pronounced ap-a-tow'-sis [1] ) is one of the main types of programmed cell death (PCD). As such, it is a proce...
Other Tags
(Date:4/27/2015)... 27, 2015 As ISO 27001 has ... for companies of all sizes and in all industries, ... companies prepare for ISO 27001 certification. The information security ... prepare them for ISO 27001 certification. Pivot Point's commitment ... by the number of Lead Implementers and Auditors the ...
(Date:4/27/2015)... Sitting or standing for long periods of time ... for those whose occupation requires them to be sitting while ... or to be on their feet for most of the ... more severe and longer lasting. These people suffer from a ... of Northeast Houston Vein Center is offering tips on how ...
(Date:4/27/2015)... NJ (PRWEB) April 27, 2015 ... firm, is proud to announce their sponsorship of ... Warren Counties. Girls on the Run is ... third through eighth grade. The program is delivered ... with uplifting workouts aimed to develop the whole ...
(Date:4/27/2015)... April 27, 2015 A' Design Award ... project SMRT IMAGE Lumica by Boombang Inc Design Team ... A' Design Award in Scientific Instruments, Medical Devices and ... on SMRT IMAGE Lumica, Boombang Inc Design Team, the ... IMAGE Lumica explained “SMRT Image Lumica is a two-way ...
(Date:4/27/2015)... On May 15, Mount Soma Ashram ... campaign to raise awareness of the vision of Mount ... Somesvara Temple. Ironically, when many of these people moved ... thought they were leaving the social and technological world ... of meditation, service to a higher cause, deep introspection, ...
Breaking Medicine News(10 mins):Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3Health News:TayganPoint Consulting Group Announces Sponsorship of Girls on the Run 2Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:Mount Soma Monks Do Social Media 2
(Date:4/14/2015)... April 14, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... the 2015 New York Design Awards under the category  ... York City Design Awards are part of a global ... 2,500 ratings from the marketplace, industry and judging panel. ...
(Date:4/13/2015)... -- higi, a leading cloud-based consumer engagement platform that provides ... their communities around health and wellness, announced today the ... ... convenient vehicle to receive validated health information from consumers. ... API will allow higi,s trusted partners, on a user ...
(Date:4/9/2015)... SAN JOSE, Calif. , April 9, 2015 /PRNewswire/ ... of human interface solutions, announced today that it will ... 2015 on Thursday, April 23, 2015, after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2
Other Contents